FDA Inspection 1178695 — James H. Kopp, M.D.
The FDA completed an inspection of James H. Kopp, M.D. on Aug 25, 2022 in Anderson, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 25, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Anderson, SC (United States)
Additional Details
Clinical Investigator (CI)